
Rheumatology Month in Review: March 2025
March brought significant advancements in rheumatology, spanning gout, psoriatic arthritis (PsA), and fibromyalgia. In gout, SAP-001 from Shanton Pharma showed best-in-class efficacy in a phase 2b trial, with most patients achieving target uric acid levels …